Article
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
14 Oct 2022
Abstract excerpt
The discovery and development of the CRISPR/Cas system is a milestone in precise medicine. CRISPR/Cas nucleases, base-editing (BE) and prime-editing (PE) are three genome editing technologies derived from CRISPR/Cas. In recent years, CRISPR-based genome editing technologies have created immense therapeutic potential with safe and efficient viral or non-viral delivery systems. Significant progress has been made in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
